These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I. Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717 [Abstract] [Full Text] [Related]
23. Immunohistochemical expression of androgen receptor in salivary gland cancers. Sygut D, Bień S, Ziółkowska M, Sporny S. Pol J Pathol; 2008 Aug; 59(4):205-10. PubMed ID: 19391487 [Abstract] [Full Text] [Related]
24. p63 immunostaining in destained bronchoscopic cytological specimens. Shtilbans V, Szporn AH, Wu M, Burstein DE. Diagn Cytopathol; 2005 Apr; 32(4):198-203. PubMed ID: 15754365 [Abstract] [Full Text] [Related]
25. Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study. Jalaly JB, Sanati S, Chernock RD, Dibe DG, El-Mofty SK. Head Neck Pathol; 2018 Dec; 12(4):488-492. PubMed ID: 29302899 [Abstract] [Full Text] [Related]
26. Carcinoma ex pleomorphic adenoma of the buccal region is composed of salivary duct carcinoma and squamous cell carcinoma components. Nakamori K, Ohuchi T, Hasegawa T, Hiratsuka H. Int J Oral Maxillofac Surg; 2009 Oct; 38(10):1116-8. PubMed ID: 19467841 [Abstract] [Full Text] [Related]
27. Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis. Moriki T, Ueta S, Takahashi T, Mitani M, Ichien M. Cancer; 2001 Oct 25; 93(5):344-50. PubMed ID: 11668470 [Abstract] [Full Text] [Related]
28. Parapharyngeal [corrected] salivary duct carcinoma involving the cavernous sinus. Larbcharoensub N, Leopairut J, Tungkeeratichai J, Laothamatas J. J Med Assoc Thai; 2007 Aug 25; 90(8):1665-8. PubMed ID: 17927000 [Abstract] [Full Text] [Related]
29. Salivary duct carcinoma metastatic to inguinal lymph node: a case report of salivary duct carcinoma with distant metastasis diagnosed by fine-needle aspiration. Bhalla R, Parker DC, Tadros TS. Diagn Cytopathol; 2006 Jan 25; 34(1):41-4. PubMed ID: 16355374 [Abstract] [Full Text] [Related]
30. The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center. Mayer M, Wolber P, Prinz J, Jansen L, Esser J, Shabli S, Quaas A, Klußmann JP, Sharma SJ, Nachtsheim L, Arolt C. Eur Arch Otorhinolaryngol; 2024 Jul 25; 281(7):3779-3789. PubMed ID: 38587651 [Abstract] [Full Text] [Related]
31. [Effective treatment by both anti-androgen therapy and chemotherapy for a patient with advanced salivary duct carcinoma]. Kuroda H, Sakurai T, Yamada M, Uemura N, Ono M, Abe T, Fujii S, Maeda M, Kohda K, Obata M, Ando M, Iyama S, Kato J. Gan To Kagaku Ryoho; 2011 Apr 25; 38(4):627-30. PubMed ID: 21498992 [Abstract] [Full Text] [Related]
32. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours. Andreadis D, Epivatianos A, Mireas G, Nomikos A, Poulopoulos A, Yiotakis J, Barbatis C. J Laryngol Otol; 2006 Apr 25; 120(4):298-304. PubMed ID: 16623973 [Abstract] [Full Text] [Related]
33. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma. Soares CD, de Lima Morais TM, Carlos R, Martins MD, de Almeida OP, Mariano FV, Altemani A. Hum Pathol; 2019 Oct 25; 92():59-66. PubMed ID: 31400353 [Abstract] [Full Text] [Related]
34. Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis. Ramer N, Wu H, Sabo E, Ramer Y, Emanuel P, Orta L, Burstein DE. Cancer; 2010 Jan 01; 116(1):77-83. PubMed ID: 19877114 [Abstract] [Full Text] [Related]
35. Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD. Cancer; 1996 Jan 15; 77(2):223-30. PubMed ID: 8625227 [Abstract] [Full Text] [Related]
36. Immunohistochemical distinction of cutaneous spindle cell carcinoma. Morgan MB, Purohit C, Anglin TR. Am J Dermatopathol; 2008 Jun 15; 30(3):228-32. PubMed ID: 18496422 [Abstract] [Full Text] [Related]
37. [Clinicopathological analysis of 40 cases of salivary duct carcinoma]. Lin N, Cai JH, Xu MJ, Kang P, Cheng ZF, He W. Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Jun 09; 54(6):416-419. PubMed ID: 31177683 [Abstract] [Full Text] [Related]
38. Obligate basal cell component in salivary oncocytoma facilitates distinction from acinic cell carcinoma. Weiler C, Reu S, Zengel P, Kirchner T, Ihrler S. Pathol Res Pract; 2009 Jun 09; 205(12):838-42. PubMed ID: 19646823 [Abstract] [Full Text] [Related]